Page last updated: 2024-11-07

u 99194a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

(5,6-dimethoxyindan-2-yl)dipropylamine: has 20-fold preference for D3 versus D2 dopamine receptors [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119195
CHEMBL ID543760
MeSH IDM0228883

Synonyms (18)

Synonym
u 99194a
(5,6-dimethoxyindan-2-yl)dipropylamine
1h-inden-2-amine, 2,3-dihydro-5,6-dimethoxy-n,n-dipropyl-, hydrochloride
u-99194a
5,6-dimethoxy-n,n-dipropyl-2,3-dihydro-1h-inden-2-amine hydrochloride
pnu 99194a
pnu-99194a
153570-58-2
CHEMBL543760
83598-46-3
unii-e5a8b0v7p3
e5a8b0v7p3 ,
1h-inden-2-amine, 2,3-dihydro-5,6-dimethoxy-n,n-dipropyl-, hydrochloride (1:1)
u99194a
5,6-dimethoxy-n,n-dipropyl-2,3-dihydro-1h-inden-2-amine--hydrogen chloride (1/1)
DTXSID50934780
Q27276891
5,6-dimethoxy-n,n-dipropyl-2,3-dihydro-1h-inden-2-amine;hydrochloride

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Thus, the inhibitory dose-response effects of a D2-preferring [sulpride], a D3-preferring [U 99194A] and combination of varying doses of these antagonists [sulpride + U 99194A] were evaluated on the ability of the cited agonists to produce vomiting."( The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew).
Ahmad, B; Darmani, NA; Zhao, W, 1999
)
0.52
"0 mg/kg) produced a rightward shift in the (+)-7-OH-DPAT dose-response curve."( Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A.
Baker, LE; Christian, AJ; Goodwin, AK, 2001
)
0.31
"The goal of the present investigation was to study a full dose-response of quinpirole in production of species-specific 50 kHz ultrasonic vocalizations in rats, and to study involvement of D2 and D3 dopamine receptors in this response."( Quinpirole-induced 50 kHz ultrasonic vocalization in the rat: role of D2 and D3 dopamine receptors.
Brudzynski, SM; Komadoski, M; St Pierre, J, 2012
)
0.38
" We report a new method that does not employ a radiolabel for simultaneously defining in vivo receptor occupancy of D(3) and D(2) receptors in rat brain after systemic dosing using the tracer epidepride (N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-5-iodo-2,3-dimethoxybenzamide)."( In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder.
Barth, V; Giros, B; Gleason, SD; Johansson, AM; Need, AB; Nomikos, GG; Overshiner, C; Perry, K; Tzavara, ET; Wade, M; Witkin, JM, 2013
)
0.39
" Microinjection of the preferential D(3) agonist 7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) into lobe 9 of the cerebellum significantly reduced spontaneous locomotor activity with a U-shaped dose-response curve."( Role of cerebellar dopamine D(3) receptors in modulating exploratory locomotion and cataleptogenicity in rats.
Andatsu, S; Kizu, T; Miyoshi, S; Ohno, Y; Sato, M; Shimizu, S; Sugiuchi, T; Tatara, A, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID48365Inhibition of the positive chronotropic effect of stimulation of the cardioaccelerator nerve in the anesthetized cat.1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
Conformationally restricted congeners of dopamine derived from 2-aminoindan.
AID62450Inhibitory binding activity against dopamine receptor using [3H]spiperone as the radioligand in striatal tissue of calf brain.1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
Conformationally restricted congeners of dopamine derived from 2-aminoindan.
AID62448Inhibitory binding activity against dopamine receptor using [3H]ADTN as the radioligand in striatal tissue of calf brain.1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
Conformationally restricted congeners of dopamine derived from 2-aminoindan.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (59)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.69)18.7374
1990's19 (32.20)18.2507
2000's27 (45.76)29.6817
2010's12 (20.34)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other62 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]